UK markets open in 6 hours 8 minutes

BioPharma Credit PLC (BPCP.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
69.20-0.10 (-0.14%)
At close: 03:26PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 1.08B
Enterprise value N/A
Trailing P/E 10.58
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)10.38
Price/book (mrq)0.80
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 3-10.27%
S&P500 52-week change 325.01%
52-week high 30.81
52-week low 30.00
50-day moving average 30.73
200-day moving average 30.70

Share statistics

Avg vol (3-month) 314.7k
Avg vol (10-day) 314.34k
Shares outstanding 51.37B
Implied shares outstanding 6N/A
Float 81.06B
% held by insiders 16.28%
% held by institutions 141.26%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.07
Trailing annual dividend yield 30.10%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 79.90%
Operating margin (ttm)65.59%

Management effectiveness

Return on assets (ttm)4.98%
Return on equity (ttm)8.10%

Income statement

Revenue (ttm)135.74M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)-59.80%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)108.45M
Diluted EPS (ttm)0.06
Quarterly earnings growth (yoy)-67.10%

Balance sheet

Total cash (mrq)135.05M
Total cash per share (mrq)0.11
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.79
Book value per share (mrq)1.03

Cash flow statement

Operating cash flow (ttm)123.18M
Levered free cash flow (ttm)56.88M